Research News From September 14, 2016
advertisement
- Home Use of Day-and-Night Hybrid Closed-Loop Insulin Delivery in Suboptimally Controlled Adolescents With Type 1 Diabetes: A 3-Week, Free-Living, Randomized Crossover Trial.
- A minimized human insulin-receptor-binding motif revealed in a Conus geographus venom insulin. See also Snails’ speedy insulin: Bio-inspired insulin may act three times faster than current products and Snail venom holds key to better diabetes treatments.
- Increased skin autofluorescence of children and adolescents with type 1 diabetes despite a well-controlled HbA1c: results from a cohort study. Free full text available in HTML and PDF formats.
- Skin Autofluorescence is Associated with Early-stage Atherosclerosis in Patients with Type 1 Diabetes.
- Incomplete immune response to coxsackie B viruses associates with early autoimmunity against insulin.
- Coincidence of PTPN22 c.1858CC and FCRL3 -169CC genotypes as a biomarker of preserved residual β-cell function in children with type 1 diabetes.
- Beta cell function and ongoing autoimmunity in long-standing, childhood onset type 1 diabetes.
- Development of Insulin Detemir/Insulin Aspart Cross-Reacting Antibodies Following Treatment with Insulin Detemir: 104-week Study in Children and Adolescents with Type 1 Diabetes Aged 2-16 Years.
- Clinical Benefit of Islet Xenotransplantation for the Treatment of Type 1 Diabetes. Free full text available in HTML and PDF formats.